[December 31, 2014]

UPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc. - UPI

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Uroplasty, Inc. (NasdaqCM:UPI) ("Uroplasty") in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM:VSCI).

Click here to learn about the case: http://docs.wongesq.com/UPI-Info-Request-Form-541. There is no cost or obligation to you.

Underthe terms of the transaction, Uroplasty shareholders will receive 3.6331 shares of Vision-Sciences for each share of Uroplasty stock they own. The investigation concerns whether the Board of Uroplasty breached their fiduciary duty to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Vision-Sciences is underpaying for Uroplasty shares.

If you own common stock in Uroplasty and wish to obtain additional information, please contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/UPI-Info-Request-Form-541.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

[ Back To TMCnet.com's Homepage ]